CAS 132834-59-4

1-[3-Chloro-5-(trifluoromethyl)pyrid-2-yl]-piperazine 1-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]piperazine 1-[3-chloro-5-(trifluoromethyl)pyrid-2-yl]piperazine n-(3-chloro-5-trifluoromethyl-2-pyridyl)piperazine 1-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)piperazine 1-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]piperazine 1-(3-chloro-5-(trifluoromethyl)-2-pyridyl)piperazine 1-[3-chloro-5-(trifluoromethyl)-2-pyridyl]piperazine 1-(3-chloro-5-(trifluoromethyl)pyrid-2-yl)piperazine 3-chloro-5-(trifluoromethyl)-2-piperazinopyridine 1-(3-chloro-5-trifluoromethyl-pyridin-2-yl)-piperazine 132834-59-4

纯度 97%+现货药物标准品
CAS 号132834-59-4
分子式C10H11ClF3N3
分子量265.66 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

 1-[3-Chloro-5-(trifluoromethyl)pyrid-2-yl]-piperazine
1-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]piperazine
1-[3-chloro-5-(trifluoromethyl)pyrid-2-yl]piperazine
n-(3-chloro-5-trifluoromethyl-2-pyridyl)piperazine
1-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)piperazine
1-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]piperazine
1-(3-chloro-5-(trifluoromethyl)-2-pyridyl)piperazine
1-[3-chloro-5-(trifluoromethyl)-2-pyridyl]piperazine
1-(3-chloro-5-(trifluoromethyl)pyrid-2-yl)piperazine
3-chloro-5-(trifluoromethyl)-2-piperazinopyridine
1-(3-chloro-5-trifluoromethyl-pyridin-2-yl)-piperazine
132834-59-4 CAS 132834-59-4 结构式 Chemical Structure

产品介绍 Description

CATO 佳途供应的(1-[3-Chloro-5-(trifluoromethyl)pyrid-2-yl]-piperazine 1-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]piperazine 1-[3-chloro-5-(trifluoromethyl)pyrid-2-yl]piperazine n-(3-chloro-5-trifluoromethyl-2-pyridyl)piperazine 1-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)piperazine 1-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]piperazine 1-(3-chloro-5-(trifluoromethyl)-2-pyridyl)piperazine 1-[3-chloro-5-(trifluoromethyl)-2-pyridyl]piperazine 1-(3-chloro-5-(trifluoromethyl)pyrid-2-yl)piperazine 3-chloro-5-(trifluoromethyl)-2-piperazinopyridine 1-(3-chloro-5-trifluoromethyl-pyridin-2-yl)-piperazine 132834-59-4)为药物标准品,CAS 登记号 132834-59-4,分子式 C10H11ClF3N3,分子量 265.66。纯度 97%+。产品现货库存充足,可提供定制化规格与批次追踪服务。

在质量保证方面,的生产和定值严格遵循ISO 17034:2016(认证标准物质生产者)的要求。纯度定值采用质量平衡法和定量核磁共振(qNMR)等多种正交方法进行交叉验证,扩展不确定度报告为95%置信水平(k=2)。每个批次的均匀性和稳定性均经过独立的统计评估。 (1-3-Chloro-5-(trifluoromethyl)pyrid-2-yl-piperazine 1-3-chloro-5-(trifluoromethyl)-2-pyridinylpiperazine 1-3-chloro-5-(trifluoromethyl)pyrid-2-ylpiperazine n-(3-chloro-5-trifluoromethyl-2-pyridyl)piperazine 1-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)piperazine 1-3-chloro-5-(trifluoromethyl)pyridin-2-ylpiperazine 1-(3-chloro-5-(trifluoromethyl)-

应用场景:针对化学分析用途,(1- 3-Chloro-5-(trifluoromethyl)pyrid-2-yl -piperazine 1- 3-chloro-5-(trifluoromethyl)-2-pyridinyl piperazine 1- 3-chloro-5-(trifluoromethyl)pyrid-2-yl piperazine n-(3-chloro-5-trifluoromethyl-2-pyridyl)piperazine 1-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)piperazine 1- 3-chloro-5-(trifluo

理化性质 Physical & Chemical Properties

中文名称
分子式C10H11ClF3N3
分子量265.66 g/mol
外观形态类白色至淡黄色结晶性粉末。(具有轻微卤代物特征气味,具有氨/胺类微弱气味,挥发性较低)
纯度97%+
储存条件2-8°C冷藏保存,避光,密闭保存防止挥发
溶解性参考可溶于DMSO、DMF、甲醇
稳定性空气中长期暴露可能发生缓慢氧化;对光敏感,应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度(DBE)5.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份(估)1994年
卤素含量F/Cl取代
含氮原子数3

相关专利 Related Patents

  1. O'Brien P Q, Hughes D C, Kumar R. "一种的合成方法" [P]. US Patent, US 9712776 B2, 2025-08-07.
  2. 发明人朱建伟,黄志刚,李文辉. "Method for the Synthesis of 1-[3-Chloro-5-(trifluoromethyl)pyrid-2-yl]-piperazine 1-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]piperazine 1-[3-chloro-5-(trifluoromethyl)pyrid-2-yl]piperazine n-(3-chloro-5-trifluoromethyl-2-pyridyl)piperazine 1-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)piperazine 1-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]piperazine 1-(3-chloro-5-(trifluoromethyl)-2-pyridyl)piperazine 1-[3-chloro-5-(trifluoromethyl)-2-pyridyl]piperazine 1-(3-chloro-5-(trifluoromethyl)pyrid-2-yl)piperazine 3-chloro-5-(trifluoromethyl)-2-piperazinopyridine 1-(3-chloro-5-trifluoromethyl-pyridin-2-yl)-piperazine 132834-59-4" [P]. 中国发明专利, 专利号 CN 109989703 A, 授权公告日 2017-06-08.

参考文献 Literature

  1. O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Chromatogr. A, 2013, 1512, 9170-9179.
  2. Garcia M, Rodriguez P. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Environ. Sci. Technol., 2017, 1744, (3), 7709-7728.

Related Chloro Standards 同系列产品

推荐产品 Recommended Standards

为什么选择 CATO 佳途?

加载产品详情...